Trial intelligence / Profile preview

SB-705498 +/- Fluticasone Propionate in Allergic Rhinitis

NCT01424397Phase 2Completed

Sponsor
GSK
Start
Apr 2011
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of SB-705498 in allergic rhinitis (AR), sponsored by GSK. Started Apr 2011; status: completed.

02

Drugs

SB-705498
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT01424397.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01424397.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call